COMMUNIQUÉS West-GlobeNewswire

TRACON Doses First Patient in Phase 1b Study of TRC105 with Opdivo® in Patients with Lung Cancer

29/11/2017 - 22:05

SAN DIEGO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

Adamis Pharmaceuticals Submits Prior Approval Supplement to FDA for the Pediatric Version of Symjepi

29/11/2017 - 22:05

SAN DIEGO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) today announced the submission of a prior approval supplement to the U.S. Food and Drug Administration (“FDA”) for a [...]

Genesis Healthcare, Inc. Receives Continued Listing Standard Notice From the NYSE

29/11/2017 - 22:01

KENNETT SQUARE, Pa., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Genesis HealthCare (“Genesis”) (NYSE: GEN ), one of the largest post-acute care providers in the United States, today announced that it received written [...]

Genmab Achieves USD 20 Million Milestone in Daratumumab Collaboration with Janssen and Updates Financial Guidance

29/11/2017 - 21:41

Company Announcement Genmab to receive USD 20 million milestone payment from Janssen Milestone triggered by progress in the Phase III study of daratumumab in combination with cyclophosphamide, bortezomib and [...]

Amphastar Announces Approval for Medroxyprogesterone Acetate Injectable Suspension, USP

29/11/2017 - 20:50

RANCHO CUCAMONGA, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH ) announced that today the U.S. Food and Drug Administration (“FDA”) granted approval of two abbreviated new [...]

Establishment Labs and OBP Medical Announce Partnership to Deliver Innovative New Tool for Advanced Breast Aesthetics Procedures

29/11/2017 - 20:35

NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today the launch [...]

Sanofi updates information on dengue vaccine

29/11/2017 - 17:37

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi updates information on dengue vaccine New analysis of long-term Dengvaxia ® data found differences in vaccine performance based on prior dengue infection [...]

Sanofi actualise l'information concernant son vaccin contre la dengue

29/11/2017 - 17:37

Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi actualise l'information concernant son vaccin contre la dengue Les résultats d'une nouvelle étude de suivi à long terme de Dengvaxia ® font [...]

Purepoint Uranium Group Inc. Announces Private Placement and First Tranche Closing

29/11/2017 - 17:00

Not for Dissemination in the United States or through U.S. Newswire Services TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Purepoint Uranium Group Inc. (TSXV:PTU) (the “Company”) announced a non-brokered private placement [...]

bioAffinity Technologies Welcomes New Board Members

29/11/2017 - 17:00

SAN ANTONIO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and Gary Rubin, CPA, to [...]

Title21 Health Solutions® Announces ISBT 128 Compliance Service, Title21 Compliance Care™

29/11/2017 - 17:00

PLEASANTON, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Title21 Health Solutions, “Title21,” an innovator of integrated enterprise software for cell therapy and blood and marrow transplant programs supporting high-quality [...]

Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders

29/11/2017 - 16:30

WOBURN, Mass., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that the Special Meeting of Stockholders scheduled for today to vote on a proposal to decrease the number of [...]

American Health Council Elects Dr. Dorina Leibu to Physician Board

29/11/2017 - 16:00

NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Dr. Dorina Leibu, Attending Anesthesiologist at North American Partners in Anesthesia (NAPA), has been elected to the American Health Council’s Board of Physicians. With [...]

iKang Healthcare Group, Inc. Extends Shareholder Rights Plan

29/11/2017 - 15:34

BEIJING, Nov. 29, 2017 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), announced today that its Board of Directors has unanimously approved the extension of its Rights [...]

Ritter Pharmaceuticals Presents at the 10th Annual LD Micro Conference on December 5, 2017

29/11/2017 - 15:30

LOS ANGELES, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the human gut microbiome to [...]

scPharmaceuticals Inc. Announces Closing of Over-Allotment Option in its Initial Public Offering

29/11/2017 - 15:23

BURLINGTON, Mass., Nov. 29, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the “Company” or “scPharmaceuticals”) (Nasdaq: SCPH ), a pharmaceutical company focused on developing and commercializing products that have [...]

Cesca Therapeutics Inc. Announces Pricing of Public Offering of up to 900,000 shares of Common Stock

29/11/2017 - 15:07

RANCHO CORDOVA, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]

NSS Labs Adds Dina Bruzek as Senior Vice President of Products

29/11/2017 - 15:00

AUSTIN, Texas, Nov. 29, 2017 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based cybersecurity guidance, today announced that Dina Bruzek has joined the company as Senior [...]

International Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease

29/11/2017 - 14:30

CARLSBAD, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company [...]